
Sabinsa’s Boswellin® super reported In japanese study to show improvement in knee pain

European journal publishes article on Sami/Sabinsa oil control moisturizer safety and efficacy

US district court holds Aegle Bios liable for willful infringement of Sabinsa’s Tetrahydrocurcuminoid patent

Sabinsa’s VP scientific affairs Anurag Pande Ph.D. speaks at Nutraceutical and Functional Food Summit in Beijing

Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent

Sabinsa’s Curcumin C3 Complex® in combination with Omega-3s found to have synergistic effect

Sabinsa on Wheels science summit In Tokyo

Sabinsa’s VP scientific affairs Dr. Anurag Pande to present On LactoSpore® At 4th microbiome R&D and business collaboration forum

Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports

Sabinsa to highlight recent published studies, new canadian health claims at Supplyside West

Sabinsa and Chemill Reach licensing agreement Sabinsa’s Tetrahydrocurcuminoids patent honored

Sabinsa receives approval for New Health Claims on Curcumin C3 Complex® and Curcumin C3 Reduct® in Canada

Sabinsa corporation defends proprietary distinctiveness in Its brand “Boswellin”

Sabinsa achieves significant canadian health claim on IBS for shelf stable probiotic LactoSpore®

Sami-Sabinsa recognized by Global Health & Pharma as the “BEST International Life Science Company” and “Most Innovative Inflammatory Condition Treatment”

Sabinsa’s parent company Sami Labs recognized for excellence in research and development

Sabinsa / Sami labs recognized for export excellence by karnataka government trade promotion centre

Sabinsa Europe and Healthspan Ltd. enter into Curcumin C3 Complex® supply agreement

Sami/Sabinsa sponsors ayurveda medical association national cancer treatment seminar: Ayurcan

Sabinsa Europe initiates legal proceedings against a former employee and a competitor, bioactives, for theft of customer database, financial data and proprietary sales information

New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®

Sabinsa defends Tetrahydrocurcuminoids patent with legal action

Resveratrol and Sabinsa’s BioPerine® on mitochondrial capacity with exercise

Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics

Metabolic syndrome study on Sabinsa's Curcumin C3 Complex® honored with university research of the year award

Sabinsa received "No Questions" letter from US FDA on GRAS Status for LactoSpore®

Sabinsa to feature LactoSpore® at New York society of Cosmetic Chemists Suppliers' Day - Booth # 1246

Sabinsa to feature LactoSpore®, Sabeet® and Curcumin Uc3 Clear™ at Vitafoods - Stand #: H21

Sabinsa on wheels science summit in Germany hosts key customers and industry experts

Sabinsa founder Dr. Muhammed Majeed honored as Industry Legend

Sabinsa founder Dr. Majeed honored with Global Innovation & Excellence Award for 110 patents, 15 patents recently added

Stability research published on Sabinsa's LactoSpore® shelf stable probiotic for functional foods
